The American Society for Microbiology’s utmost priority is the health and safety of our meeting participants. Therefore, we are actively evaluating conditions to develop meeting policies that ensure a safe environment for all participants traveling to Boston for the 2023 ASM/ESCMID Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance. In addition, because conditions and safety guidelines are constantly evolving, ASM closely monitors current state, federal and local COVID-19 guidelines for in-person gatherings and travel restrictions.
ASM ESCMID Health & Safety Policies
Requirements for entry to the conference are subject to change based on ASM policies, governmental regulations, venue requirements or other mandates applicable to the meeting. Therefore, participants must comply with all health and safety policies before attending the conference. Please continue to monitor this page for updates to the health and safety policies.
Health Attestation
Before entering the conference meeting venues, participants must attest they have not:
Been diagnosed with or tested positive for COVID-19 within the past 5 days.
Been directed to self-isolate by a public health authority or healthcare provider due to potential exposure to COVID-19 within the past 5 days.
Had any symptoms associated with COVID-19 infection, nor had any symptoms in the past 5 days, including fever of over 100.0; cough (not attributed to a pre-existing condition); shortness of breath or difficulty breathing; fatigue; muscle or body aches; loss of taste or smell; sore throat; congestion or runny nose; nausea or vomiting or diarrhea.
Had close contact (within 6 feet) with anyone under known quarantine or diagnosed with COVID-19 or showing systems of COVID-19 in the past 5 days.
